Madhav Goyal

Madhav Goyal

Auto-generated profile, based on publicly available information

Madhav Goyal

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MGMadhav Goyal
Madhav Goyal
SSSonal Singh
Sonal Singh
ESErica M. S. Sibinga
Erica M. S. Sibinga
NGNeda F. Gould
Neda F. Gould
ARAnastasia Rowland-Seymour
Anastasia Rowland-Seymour
JHJennifer A. Haythornthwaite
Jennifer A. Haythornthwaite
Many people use meditation to treat stress and stress-related conditions and to promote general health.1,2 To counsel patients appropriately, clinicians need to know more about meditation programs and how they can affect health outcomes. Meditation training programs vary in several ways, including the type of mental activity promoted, the amount of training recommended, the use and qualifications of an instructor, and the degree of emphasis on religion or spirituality. Some meditative techniques are integrated into a broader alternative approach that includes dietary and/or movement therapies (eg, ayurveda or yoga).

24 October 2007 in JAMA
Verified
Journal Article
Open access
PDF file
PPPriyanka Pandey
Priyanka Pandey
ASAshwini R. Sehgal
Ashwini R. Sehgal
MRMichelle Riboud
Michelle Riboud
DLDavid Levine
David Levine
MGMadhav Goyal
Madhav Goyal
The delivery of health and social services is often inadequate in developing countries such as India in part because of limited resources allocated by governments and donor agencies.1,2 However, increased spending by itself may not be sufficient to improve outcomes. Efficiently targeting resources to impoverished communities and getting public workers to perform their duties have remained significant challenges for many public services worldwide.1,3-5

14 June 2021 in Pain
Verified
Journal Article
Closed access
SBShana A.B. Burrowes
Shana A.B. Burrowes
OGOlga Goloubeva
Olga Goloubeva
KSKristen Stafford
Kristen Stafford
PMPatrick F. McArdle
Patrick F. McArdle
MGMadhav Goyal
Madhav Goyal
DSDavid A. Seminowicz
David A. Seminowicz
Patients with migraine suffer from high morbidity related to the repeated headache attacks, characteristic of the disorder, poor sleep, and a high prevalence of comorbid psychosocial disorders. Current pharmacological therapies do not address these aspects of migraine, but nonpharmacological treatments such as mindfulness-based stress reduction (MBSR) have been shown to improve both pain and psychological well-being. In this secondary analysis, we examined the change over time in sleep quality and psychosocial outcomes from the magnetic resonance imaging outcomes for mindfulness meditation clinical trial and assessed how these mediated treatment response (50% reduction in headache frequency postintervention). We also examined the relationship between baseline values and treatment response. The trial (primary outcomes previously reported) included 98 patients with episodic migraine randomized to either enhanced MBSR (MBSR+) or stress management for headache. They completed psychosocial questionnaires and headache diaries at baseline (preintervention), midintervention (10 weeks after baseline), and postintervention (20 weeks after baseline). There was a significant improvement in sleep quality from baseline to postintervention (P = 0.0025) in both groups. There were no significant changes from baseline or between groups in anxiety, depression, and stress. There was also no significant association between baseline scores and treatment response. Mediation analysis showed a significant indirect effect of 6% for sleep: In other words, small improvements in sleep may have contributed to the efficacy of MBSR+. Trial registration: NCT02133209.

1 June 2010 in The Journal of Alternative and Complementary Medicine
Verified
Journal Article
Closed access
MGMadhav Goyal
Madhav Goyal
JHJennifer Haythornthwaite
Jennifer Haythornthwaite
DLDavid Levine
David Levine
DBDiane Becker
Diane Becker
DVDhananjay Vaidya
Dhananjay Vaidya
DFDaniel Ford
Daniel Ford
Objective: The objective of this study was to assess patient interest in intensive meditation training for chronic symptoms. Design and setting: This was a cross-sectional anonymous survey among six chronic disease clinics in Baltimore including Chronic Kidney Disease, Crohn's Disease, Headache, Renal Transplant Recipients, General Rheumatology, and lupus clinic. Subjects: Subjects were 1119 consecutive patients registering for their appointments at these clinics. Outcome measures: Outcome measures were 6-month pain, global symptomatology, four-item perceived stress scale, use of complementary and alternative medicine (CAM) therapies, and attitudes toward use of meditation for managing symptoms. We then gave a scripted description of an intensive, 10-day meditation training retreat. Patient interest in attending such a retreat was assessed. Results: Seventy-seven percent (77%) of patients approached completed the survey. Fifty-three percent (53%) of patients reported moderate to severe pain over the past 6 months. Eighty percent (80%) reported use of some CAM therapy in the past. Thirty-five percent (35%) thought that learning meditation would improve their health, and 49% thought it would reduce stress. Overall, 39% reported interest in attending the intensive 10-day meditation retreat. Among those reporting moderate to severe pain or stress, the percentages were higher (48% and 59%). In a univariate analysis, higher education, nonworking/disabled status, female gender, higher stress, higher pain, higher symptomatology, and any CAM use were all associated with a greater odds of being moderately to very interested in an intensive 10-day meditation retreat. A multivariate model that included prior use of CAM therapies as predictors of interest in the program fit the data significantly better than a model not including CAM therapies (p = 0.0013). Conclusions: Over 50% of patients followed in chronic disease clinics complain of moderate to severe pain. Patients with persistent pain or stress are more likely to be interested in intensive meditation.

22 March 2016 in JAMA
Verified
Journal Article
Closed access
PDF file
MGMadhav Goyal
Madhav Goyal
JHJennifer A. Haythornthwaite
Jennifer A. Haythornthwaite
The substantial increase in clinical trials of mindfulness meditation over the past 2 decades reflects an increasing interest in using mindfulness approaches to treat various symptoms and disorders.1-3 For example, mindfulness-based stress reduction (MBSR), a semistandardized 8-week program created in 1979, has been used for many of these trials and is based on meditation techniques.4 These meditation techniques were not intended to cure any specific health problems. Rather, they were intended as a way to deal with stress and address adverse life experiences by increasing awareness of breathing, thoughts, and bodily sensations and learning to observe them from a detached perspective. Not reacting to these phenomena, but simply observing them, can lead to greater objectivity about how an individual thinks and feels toward them. This objectivity could lead to a different experience of the phenomena altogether and may lead to a deeper understanding of how the mind and body interact to create life experiences. Thus, this awareness of what causes life experiences could lead to reduced pain and stress through avoidance of mental and physical behaviors that promote adverse outcomes.

24 January 2023 in Mindfulness
Verified
Journal Article
Open access
PDF file
MGMadhav Goyal
Madhav Goyal
JHJennifer A. Haythornthwaite
Jennifer A. Haythornthwaite
SJSharat Jain
Sharat Jain
BPBarbara Lee Peterlin
Barbara Lee Peterlin
MMMegha Mehrotra
Megha Mehrotra
DFDaniel E. Ford
Daniel E. Ford
Objectives Preventing migraine headaches and improving the quality of life for patients with migraine remains a challenge. We hypothesized intensive meditation training would reduce the disease burden of migraine. Method An unblinded trial was analyzed as a single cohort exposed to a silent 10-day Vipassana meditation retreat that included 100 hr of sitting meditation. Participants with chronic or episodic migraine were enrolled and followed for 1 year. The primary outcome was a change in mean monthly migraine days at 12 months from baseline. Secondary outcomes included headache frequency and intensity, acute medication use, work days missed, home meditation, sleep quality, general health, quality of life, migraine impact, positive and negative affect, perceived stress, mindfulness, and pain catastrophizing. Results Three hundred people were screened and 58 (19%) agreed to participate and enrolled in the intensive meditation training. Forty-six participants with chronic migraine (≥ 15 headaches/month of which ≥ 8 were migraines) and 12 with episodic migraine (< 15 and ≥ 4 migraines/month) attended and 45 (78%) completed the retreat. At 12 months, the average migraine frequency was reduced by 2.7 days (from 16.6 at baseline) per 28 days (95%CI − 4.3, − 1.3) and headaches by 3.4 (20.1 at baseline) per 28 days (− 4.9, − 1.9). Fifty percent responder rate was 29% for migraine. Acute medication use dropped by an average of 2.2 days (− 3.9, − 0.5) per 28 days, and participants reported 2.3 fewer days (− 4.0, − 0.5) on which they reduced their activity due to migraines. The most striking and promising effects were in several secondary outcomes, including migraine-specific quality of life, pain catastrophizing, and perceived stress. The significant improvements observed immediately following the intervention were sustained at 12 months follow-up. Conclusions Training in Vipassana meditation via a 10-day retreat may reduce the frequency and burden of migraine. Preregistration ClinicalTrials.gov: NCT00663585.